Luke Barbara, Brown Morton B, Misiunas Ruta, Anderson Elaine, Nugent Clark, van de Ven Cosmas, Burpee Barbara, Gogliotti Shirley
Department of Epidemiology and Public Health, University of Miami School of Medicine, Fla., USA.
Am J Obstet Gynecol. 2003 Oct;189(4):934-8. doi: 10.1067/s0002-9378(03)01054-8.
This study was undertaken to evaluate the effect of a prenatal nutrition and education program on twin pregnancy, neonatal, and early childhood outcomes.
This prospective intervention study of women who participated in a specialized program (Program Pregnancies) versus nonparticipants included twice-monthly visits, dietary prescription of 3000 to 4000 kcal per day, multimineral supplementation, and patient education.
Program Pregnancies were associated with improved pregnancy outcomes (preeclampsia, adjusted odds ratio [AOR] 0.41, 95% CI, 0.23-0.75; preterm premature rupture of membranes, AOR 0.35, 95% CI, 0.20-0.60; delivery <36 weeks, AOR 0.62, 95% CI, 0.43-0.89; low birth weight, AOR 0.42, 95% CI, 0.29-0.61), significantly longer gestations (+7.6 days), higher birth weights (+220 g), lower neonatal morbidity (retinopathy of prematurity, necrotizing enterocolitis, intraventricular hemorrhage, or ventilator support, AOR 0.44, 95% CI, 0.31-0.62), length of stay (-5.3 days), and cost per twin (-14,023 dollars). Through 3 years of age, program children were significantly less likely to be rehospitalized (AOR 0.31, 95% CI, 0.11-0.91) or to be developmentally delayed (AOR 0.65, 95% CI, 0.44-0.96).
Program participation was associated with improved outcomes at birth and through age 3 years.
本研究旨在评估一项产前营养与教育项目对双胎妊娠、新生儿及幼儿期结局的影响。
这项前瞻性干预研究将参与一个专门项目(妊娠项目)的女性与未参与者进行对比,包括每月两次访视、每日3000至4000千卡的饮食处方、多种矿物质补充以及患者教育。
妊娠项目与改善的妊娠结局相关(子痫前期,调整优势比[AOR]0.41,95%置信区间[CI],0.23 - 0.75;胎膜早破,AOR 0.35,95% CI,0.20 - 0.60;孕周<36周分娩,AOR 0.62,95% CI,0.43 - 0.89;低出生体重,AOR 0.42,95% CI,0.29 - 0.61),妊娠期显著延长(+7.6天),出生体重增加(+220克),新生儿发病率降低(早产儿视网膜病变、坏死性小肠结肠炎、脑室内出血或呼吸机支持,AOR 0.44,95% CI,0.31 - 0.62),住院时间缩短(-5.3天),以及每个双胎儿的费用降低(-14,023美元)。至3岁时,参与项目的儿童再次住院(AOR 0.31,95% CI,0.11 - 0.91)或发育迟缓(AOR 0.65,95% CI,0.44 - 0.96)的可能性显著降低。
参与项目与出生时及3岁时改善的结局相关。